ROWLINGS COLIN E

SVP, Pharm. Research & Devel. at ADVANCIS PHARMACEUTICAL CORP · on record since Jan 28, 2005

Insider trading activity of ROWLINGS COLIN E

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Value · USD	Src
ADVANCIS PHARMACEUTICAL CORP	Jan 28, 2005	AwardD	65,000	—	SEC
ADVANCIS PHARMACEUTICAL CORP	Feb 27, 2004	AwardD	80,000	—	SEC
ADVANCIS PHARMACEUTICAL CORP	Oct 20, 2003	AwardD	8,196	—	SEC

Company	Filed	Type	Qty	Value · USD	Src
ADVANCIS PHARMACEUTICAL CORP	Jan 28, 2005	AwardD	65,000	—	SEC
ADVANCIS PHARMACEUTICAL CORP	Feb 27, 2004	AwardD	80,000	—	SEC
ADVANCIS PHARMACEUTICAL CORP	Oct 20, 2003	AwardD	8,196	—	SEC